Prediction of hemolytic peptides and their hemolytic concentration
Abstract Peptide-based drugs often fail in clinical trials due to their toxicity or hemolytic activity against red blood cells (RBCs). Existing methods predict hemolytic peptides but not the concentration (HC50) required to lyse 50% of RBCs. This study develops classification and regression models t...
Saved in:
Main Authors: | Anand Singh Rathore, Nishant Kumar, Shubham Choudhury, Naman Kumar Mehta, Gajendra P. S. Raghava |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-025-07615-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction of inhibitory peptides against E.coli with desired MIC value
by: Nisha Bajiya, et al.
Published: (2025-02-01) -
Acute Brucellosis Presenting as an Autoimmune Hemolytic Anemia
by: Durga Shankar Meena, et al.
Published: (2018-01-01) -
Immunotherapy-associated autoimmune hemolytic anemia
by: Uqba Khan, et al.
Published: (2017-02-01) -
A Curious Case of Hemolytic Anemia with Pseudoreticulopenia
by: Scott Mayer, et al.
Published: (2022-01-01) -
Gross Hematuria and Hemolytic Anemia in Infectious Mononucleosis
by: Chinmayi Sharma, et al.
Published: (2024-01-01)